Keywords: Braxil, Atrial fibrillation, Market forecasts, Boehringer, Pradaxa, Bayer, Xarelto, Bristol-Myers, Pfizer, Eliquis, Daiichi Sankyo, Lixiana, Decision Resources

Brazil's atrial fibrillation market to grow at 31% annually over the next five years

Article | 19 December 2012

• Print This

The Brazilian market for atrial fibrillation will increase at a rate of 31% per year from 2011 to 2016, according to health care ...

Enjoying this article? To continue reading you need to login or subscribe.